Skip to main content

Review IDs Trends in Anterior Cruciate Ligament Injury Treatments in Children

Medically reviewed by Carmen Pope, BPharm. Last updated on March 15, 2024.

By Lori Solomon HealthDay Reporter

FRIDAY, March 15, 2024 -- Lateral extra-articular tenodesis (LET) and anterolateral ligament reconstruction (ALLR) techniques for the treatment of anterior cruciate ligament in skeletally immature patients show promising results, according to a review published online March 6 in the Journal of Experimental Orthopaedics.

Martijn Dietvorst, M.D., Ph.D., from Maxima Medical Centre in Eindhoven, Netherlands, and colleagues conducted a scoping review to provide an overview of all current anterolateral augmentation procedures in skeletally immature patients and to examine surgical techniques and clinical and biomechanical outcomes.

The researchers identified 20 eligible studies, of which 17 described LET techniques, four described ALLR techniques, and one detailed both techniques. Biomechanical data were limited and showed conflicting results. Two studies compared ACL reconstruction with LET to isolated ACL reconstruction in skeletally immature children, with results favoring the combined procedure. LET and ALLR had similar outcomes.

"We found many different surgical techniques of anterolateral augmentation in this population with promising results. Future studies must evaluate the effectiveness and safety of these procedures regarding re-injuries, growth disturbances, and overconstraint,” Dietvorst said in a statement. "We believe that this review will give a complete overview of current techniques and considerations."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Perioperative Chemo Improves Progression-Free Survival in Pancreatic Cancer

TUESDAY, July 2, 2024 -- For patients with resectable pancreatic ductal adenocarcinoma (PDAC), the 12-month progression-free survival (PFS) may be increased with neoadjuvant...

Few Patients With Positive Margins After Basal Cell Excision Have Recurrence

MONDAY, July 1, 2024 -- Among patients with incompletely excised basal cell carcinoma (BCC), only about 16 percent with positive histopathologic margins have clinical recurrence...

Small Number of Procedures Account for Large Number of Opioid Prescriptions

FRIDAY, June 28, 2024 -- A small number of surgical procedures, including orthopedic procedures and cesarean delivery, account for a large proportion of opioid prescriptions...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.